Recent type 1 diabetes diagnosis?

When you find out your child has type 1 diabetes, you enter a world of finger pokes, dietary constraints, blood sugar checks and insulin shots. What you might not know is this: If your child was diagnosed with type 1 diabetes in the last 100 days, his or her pancreas may still have insulin-producing beta cells, and your child may be eligible to enroll in a study evaluating the safety and effectiveness of an investigational medication. Researchers are trying to find out whether the study medication can preserve beta cell function and possibly extend the body’s ability to create insulin.

The T1GER clinical research study for type 1 diabetes is now enrolling children and young adults between the ages of 6 and 21 who have been diagnosed with T1D in the last 100 days (additional requirements apply). The study is being conducted by doctors and specialists selected by Janssen Research & Development, LLC (a pharmaceutical company owned by Johnson & Johnson).

Learn more about the study and whether enrolling might be right for your child. Participating in this study will help advance the understanding of this study medication and may contribute to the development of new treatments for children and young adults with type 1 diabetes.

You are passing a message to a BabyCenter staff member.
For the fastest help on community guidelines violations, please click 'Report this' on the item you wish the staff to review.
For general help please read our Help section or contact us.